Status:
UNKNOWN
Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor
Lead Sponsor:
Chiang Mai University
Conditions:
Intraoperative Pain Control
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Perioperative pain relief during endoscopic transsphenoidal pituitary surgery is generally treated with opioids either morphine sulfate or fentanyl. This study will compare the traditional method of i...
Detailed Description
1. Infraorbital nerve- The infraorbital nerve exits from the infraorbital foramen. It is a branch of the maxillary nerve, the second division of the trigeminal nerve, the fifth cranial nerve. The infr...
Eligibility Criteria
Inclusion
- Adult patients
- age ≥ 18 years old
- diagnosis of pituitary tumor
- scheduled for endoscopic transsphenoidal approach to remove tumor under general anesthesia with endotracheal tube
Exclusion
- the patient is known case of allergy to dexmedetomidine
- the patient allergy to bupivacaine
- the patient does not sign a consent form to participate to the study
- the operation is changed due to cavernous sinus perforation
- the navigator and Mayfield is used to identify the tumor
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04785222
Start Date
July 1 2021
End Date
December 1 2023
Last Update
March 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.